Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc. but Wojcicki complained about the bidding process, ...

The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a California research institute, to pay $305 million for a cache of customer DNA ...

Rep. Gill grilled 23andMe's co-founder Anne Wojcicki during a House hearing where she revealed that she did not understand ...

During a hearing on the privacy implications of 23andMe selling its business, its interim CEO says 1.9 million people, or ...

Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

Privacy concerns mount as 23andMe bankruptcy sale nears. Ombudsman warns of data protection risks under nonprofit bid led by ...

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...